|
| | Publication Year | Title | Author(s) |
| 61 | Nov-2020 | Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. | Chételat, Gaël; Arbizu, Javier; Barthel, Henryk; Garibotto, Valentina; Law, Ian; Morbelli, Silvia; van de Giessen, Elsmarieke; Agosta, Federica; Barkhof, Frederik; Brooks, David J; Carrillo, Maria C; Dubois, Bruno; Fjell, Anders M; Frisoni, Giovanni B; Hansson, Oskar; Herholz, Karl; Hutton, Brian F; Jack, Clifford R; Lammertsma, Adriaan A; Landau, Susan M; Minoshima, Satoshi; Nobili, Flavio; Nordberg, Agneta; Ossenkoppele, Rik; Oyen, Wim J G; Perani, Daniela; Rabinovici, Gil D; Scheltens, Philip; Villemagne, Victor L ; Zetterberg, Henrik; Drzezga, Alexander |
| 62 | 2-Oct-2015 | Amyloid-Related memory decline in preclinical Alzheimer's Disease is dependent on APOE ε4 and is detectable over 18-months | Thai, Christine; Villemagne, Victor L ; Laws, Simon M; Ames, David; Ellis, Kathryn A; Rainey-Smith, Stephanie R; Martins, Ralph N; Masters, Colin L ; Rowe, Christopher C ; Maruff, Paul; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group |
| 63 | 2022 | Amyloid-β (Aβ)-Related Cerebral Amyloid Angiopathy Causing Lobar Hemorrhage Decades After Childhood Neurosurgery. | Kellie, Jeremy F; Campbell, Bruce C V; Watson, Rosie; Praeger, Adrian J; Nair, Girish; Murugasu, Anand; Rowe, Christopher C ; Masters, Colin L ; Collins, Steven; McLean, Catriona; Yassi, Nawaf |
| 64 | 2015 | Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. | Hollands, Simone; Lim, Yen Ying; Buckley, Rachel F; Pietrzak, Robert H; Snyder, Peter J; Ames, David; Ellis, Kathryn A; Harrington, Karra; Lautenschlager, Nicola T; Martins, Ralph N; Masters, Colin L ; Villemagne, Victor L ; Rowe, Christopher C ; Maruff, Paul |
| 65 | 1-Mar-2015 | Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. | Pietrzak, Robert H; Lim, Yen Ying; Neumeister, Alexander; Ames, David; Ellis, Kathryn A; Harrington, Karra; Lautenschlager, Nicola T; Restrepo, Carolina; Martins, Ralph N; Masters, Colin L ; Villemagne, Victor L ; Rowe, Christopher C ; Maruff, Paul |
| 66 | 2020 | Amyloid-β, Tau, and 18F-Fluorodeoxyglucose Positron Emission Tomography in Posttraumatic Stress Disorder. | Elias, Alby; Cummins, Tia; Lamb, Fiona ; Tyrrell, Regan ; Dore, Vincent; Williams, Rob; Rosenfeld, Jeffrey V; Hopwood, Malcolm; Villemagne, Victor L ; Rowe, Christopher C |
| 67 | Dec-2020 | Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort. | Chia, Puey Ling ; Russell, Prudence; Asadi, Khashi; Thapa, Bibhusal ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Eriksson, Ulf; Scott, Andrew M ; John, Thomas |
| 68 | 8-Jun-2023 | Anatomical targeting for electrode localization in subthalamic nucleus deep brain stimulation: A comparative study. | Tonroe, Thomas; McDermott, Hugh; Pearce, Patrick; Acevedo, Nicola; Thevathasan, Wesley; Xu, San San ; Bulluss, Kristian J ; Perera, Thushara |
| 69 | May-2021 | Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition. | Tan, Sherilyn; Porter, Tenielle; Bucks, Romola S; Weinborn, Michael; Milicic, Lidija; Brown, Ailsa; Rainey-Smith, Stephanie R; Taddei, Kevin; Ames, David; Masters, Colin L ; Maruff, Paul; Savage, Greg; Rowe, Christopher C ; Villemagne, Victor L ; Brown, Belinda; Sohrabi, Hamid R; Laws, Simon M; Martins, Ralph N |
| 70 | 1-Mar-2002 | Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity. | Liu, Zhanqi; Smyth, Fiona E; Renner, Christoph; Lee, Fook-Thean; Oosterwijk, Egbert; Scott, Andrew M |
| 71 | 5-Apr-2011 | Antibodies in oncology. | Pillay, Vinochani; Gan, Hui K ; Scott, Andrew M |
| 72 | 13-Nov-2023 | Antibody drug conjugates for glioblastoma: current progress toward clinical use. | Gan, Hui K ; Parakh, Sagun ; Osellame, Laura D; Cher, Lawrence M ; Uccellini, Anthony; Hafeez, Umbreen ; Menon, Siddharth; Scott, Andrew M |
| 73 | 3-Dec-2021 | Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them? | Parakh, Sagun ; Nicolazzo, Joseph; Scott, Andrew M ; Gan, Hui K |
| 74 | 8-May-2020 | Antibody Targeting of Eph Receptors in Cancer. | Janes, Peter W ; Vail, Mary E; Gan, Hui K ; Scott, Andrew M |
| 75 | 22-Mar-2012 | Antibody therapy of cancer. | Scott, Andrew M ; Wolchok, Jedd D; Old, Lloyd J |
| 76 | 1-Oct-1997 | Antibody-based immunological therapies. | Scott, Andrew M ; Welt, S |
| 77 | 16-Oct-2020 | Antibody-Drug Conjugates for Cancer Therapy. | Hafeez, Umbreen ; Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M |
| 78 | 11-Jul-2016 | Antibody-Drug Conjugates for Cancer Therapy. | Parslow, Adam C; Parakh, Sagun ; Lee, Fook-Thean; Gan, Hui K ; Scott, Andrew M |
| 79 | Nov-2017 | Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells. | Gan, Hui K ; van den Bent, Martin; Lassman, Andrew B; Reardon, David A; Scott, Andrew M |
| 80 | 2022 | Antibody-drug conjugates: beyond current approvals and potential future strategies. | Menon, Siddharth; Parakh, Sagun ; Scott, Andrew M ; Gan, Hui K |
